Medicare Advantage plans face a 29-point drop in member satisfaction driven by rising medical costs and digital engagement challenges, reports J.D. Power. Rising expenses and regulatory scrutiny pressure insurers to improve service and transparency.

The 2025 J.D. Power Medicare Advantage Study identifies declining member satisfaction and highlights how digital onboarding and transparency improve member trust across U.S. Medicare Advantage plans.

Physician incomes from Medicare have fallen over 33% since 2016 due to stagnant reimbursements and increased costs, prompting health systems to reconsider Medicare Advantage participation. This shift threatens patient access and could reshape Medicare's physician landscape.

MorningStar Laboratories launches SmartVascular Dx test in Western US with expanded payer coverage including BCBS Arizona and Medicare, enhancing vascular disease detection and reimbursement access.

Congressman Schweikert introduces H.R.3467 to auto-enroll seniors in Medicare Advantage with a three-year lock-in, raising questions on beneficiary rights and plan flexibility.

The Congressional Budget Office warns the new tax and spending law may trigger nearly $500 billion in Medicare cuts over 10 years via S-PAYGO sequestration, impacting providers, rural hospitals, and Medicare Advantage plans.

Study finds hospital involvement in Medicare ACOs does not significantly change emergency department admission rates, length of stay, or costs, suggesting current ACO models have limited impact on acute care spending.

The August 2025 EMS Financial Index from PWW Advisory Group delivers critical financial benchmarks and reimbursement trend analysis to support EMS agencies' revenue cycle management and financial stability amid changing regulations.

A Texas federal judge has denied Elevance Health's legal challenge against CMS's Medicare Advantage star ratings, reaffirming the complex regulatory framework influencing insurers' government bonus payments.

Explore how CMS's Medicare Advantage Star Rating system's opaque methodologies create regulatory arbitrage and financial risks for insurers like Elevance Health, Humana, and UnitedHealthcare, shaping the healthcare insurance landscape.